Cardiogramme
Logo   Accueil | Table des matières | Téléchargements | Liens |   Mentions légales   | Contact |Abréviations
Logo  

Bibliographie

Lectures conseillées

CHUA J, SCHWARZENBERGER J, MAHAJAN A. Optimization of pacing after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2012; 26:291-301
PATEL KD, CROWLEY R, MAHAJAN A. Cardiac electrophysiology procedures in clinical practice. Intern Anesthesiol Clin 2012; 50:90-110
STONE ME, SALTER B, FISCHER A. Perioperative management of patients with cardiac implantable electronic devices. Br J Anaesth 2011; 107(S1): i16-i26
ROZNER MA. The patient with a cardiac pacemaker or implanted defibrillator and management during anaesthesia. Curr Opin Anaesthesiol 2007; 20:261-8

STAIKOU C, CHONDROGIANNIS K, MANI A. Perioperative management of hereditary arrhythmogenic syndromes. Br J Anaesth 2012; 108:730-44
THOMPSON A, BALSER JR. Perioperative cardiac arrhythmias. Br J Anaesth 2004; 93:86-94

 

Références

1 ABRAHAM WT, FISHER WG, SMITH AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346:1845-53
2 ACKERMAN MJ, KHOSITSETH A, TESTER DJ, et al. Epinephrine-induced QT interval prolongation: A gene-specific paradoxical response in congenital long QT syndrome. Mayo Clin Proc 2002; 77:413-21
3 Albåge A, VAN DER LINDEN J, BENGTSSON L, et al. Elevations in antidiuretic hormone and aldosterone as possible causes of fluid retention in the maze procedure. Ann Thorac Surg 2001; 72:58-64
4 ALINGS M, WILDE A. Brugada syndrome: Clinical data and suggested pathophysiological mechanism. Circulation 1999; 99:666-73
5 ALLESSIE MA, BOYDEN PA, CAMM AJ, et al. Pathophysiology and prevention of atrial fibrillation. Circulation 2001; 103:769-77
6 AMAR D, ZHANG H, ROISTACHER N. The incidence and outcome of ventricular arrhythmias after noncardiac thoracic surgery. Anesth Analg 2002; 95:537-43
7 ANDERSEN HR, NIELSEN JC, THOMSEN PE. Long-term follow-up of patients from a randomized trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997; 350:1210-6
8 APFELBAUM JL, BELOTT P, CONNIS RT, et al. Practice advisory for the perioperative management of patients with cardiac implantable electronic devices: pacemakers and implantable cardioverter-defibrillators. Anesthesiology 2011; 114:247-61
9 ARANKI SF, SHAW DP, ADAMS DH, et al. Predictors of atrial fibrillation after coronary artery surgery: current trends and impact on hospital resources. Circulation 1996; 94:390-7
10 ATLEE JA. Cardiac arrhythmias: drugs and devices. Curr Opin Anaesthesiol 2001; 14:3-9
11 ATLEE JL, BERNSTEIN A. Cardiac rhythm management devices (Part I). Anesthesiology 2001; 95:1265-80
12 ATLEE JL, BERNSTEIN A. Cardiac rhythm management devices (Part II). Anesthesiology 2001; 95:1492-1506
13 AVID. The Antiarrhythmics versus Implantable Defibrillator investigators: A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337:1576-83
14 BAGSHAW SM, GALBRAITH PD, MITCHELL LB, et al. Prophylactic amiodarone for prevention of atrial fibrillation after cardiac surgery: a meta-analysis. Ann Thorac Surg 2006; 82:1927-37
15 BAROLD SS. What is cardiac resynchronization therapy ? Am J Med 2001; 111:224-32
16 BEAULIEU Y, DENAULT AY, COUTURE P, et al. Perioperative intravenous amiodarone does not reduce the burden of atrial fibrillation in patients undergoing cardiac valvular surgery. Anesthesiology 2010; 112:128-37
17 BELARDINELLI L, ISENBERG G. Isolated atrial myocytes: adenosine and acetylcholine increase potassium conductance. Am J Physiol 1983; 244:H737-47
18 BERNSTEIN AD, DAUBERT JC, FLETCHER RD, et al. The revised NASPE/BPEG generic code for antibradycardia, adaptative-rate, and multisite pacing. North American Society of Pacing and Electrophysiology / British Pacing and Electrophysiology Group. Pacing Clin Electrophysiol 2002; 25:260-4
19 BERNSTEIN AD, PARSONNET V. Survey of cardiac pacing and defibrillation in the United states in 1993. Am J Cardiol 1996; 78:187-96
20 BLAIR JR, PRUETT JK, CRUMRINE RS, BALSER JR. Prolongation of QT interval in association with the administration of large doses of opiates. Anesthesiology 1987; 67:442-3
21 BLANCHARD L, COLLARD CD. Non-antiarrhythmic agents for prevention of postoperative atrial fibrillation: role of statins. Curr Opin Anaesthesiol 2007; 20:53-6
22 BLANK R, SCHAER B, KELLER DI, et al. Qui a besoin d’un cardioverter-défibrillateur (ICD) ? Forum Med Suisse 2008; 8:332-5
23 BOOKER PD, WHYTE SD, LADUSANS EJ. Long QT syndrome and anaesthesia. Br J Anaesth 2003; 90:349-66
24 BREITHARDT OA, STELLBRINK C. Current status of resynchronization therapy. Curr Opin Anesthesiol 2004; 17:75-83
25 BRISTOW MR, SAXON LA, BOEHMER J, et al. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure: The COMPANION trial. N Engl J Med 2004; 350:2140-8
26 BROWN J, SADLER DB. Left atrial thrombi in non-rheumatic atrial fibrillation: assessment of prevalence by transesophageal echocardiography. Int J Cardiol Imaging 1993; 9:65-72
27 BRUGADA J, BRUGADA R, ANTZELEVITCH C, et al. Long-term follow-up of individuals with the electrocardiographic pattern or right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation 2002; 105:73-8
28 BRUGADA J, BRUGADA R, BRUGADA P. Right bundle-branch block and ST-segment elevation in leads V1 through V3: A marker for sudden death in patients without demonstrable structural heart disease. Circulation 1998; 97:457-60
28a BUDERA P, STRAKA Z, OSMANCIK P, et al. Comparison of cardiac surgery with left atrial surgical ablation vs cardiac surgery without atrial ablation in patients with coronary and/or valvular heart disease plus atrial fibrillation; final results of the PRAGUE-12 randomized multicenter study. Eur Heart J 2012; 33:2644-52
29 CARTWRIGHT CR, HILL LL. Anesthesia for insertion of implantable cardioverter defibrillators. Semin Cardiothorac Vasc Anesth 2000; 4:180-6
29a CAREY SM, HOCKING G. Brugada syndrome – a review of the implication for the anaesthetist. Anaesth Intensive Care 2011; 39:571-7
30 CERRONE M, NOUJAIM S, JALIFE J. The short QT syndrome as a paradigm to understand the role of potassium channels in ventricular fibrillation. J Intern Med 2006; 259:24-38
31 CHARBIT B, ALBALADEJO P, FUNCK-BRENTANO C, et al. Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron. Anesthesiology 2005; 102:1094-1100
32 CHELLO M, PATTI G, CANDURA D, et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. Crit Care Med 2006; 34:660-7
33 CHEN WT, KRISHNAN GM, SOOD N, et al. Effect of statins on atrial fibrillation after cardiac surgery: a duration and dose-response meta-analysis. J Thorac Cardiovasc Surg 2010; 140:364-72
34 CHEVALIER P, DURAND-DUBIEJ A, BURRI H. Amiodarone versus placebo and class IC drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis. J Am Coll Cardiol 2003; 41:255-62
35 CHUA J, SCHWARZENBERGER J, MAHAJAN A. Optimization of pacing after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2012; 26:291-301
36 CLARKSON CW, HONDEGHEM LM. Mechanism for bupivacaine depression of cardiac conduction : fast block of sodium channels during action potential with slow recovery from block during diastole. Anesthesiology 1985; 62:396-405
37 CLELAND JG, DAUBERT J, ERDMAN E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352:1539-49
38 CORDERY R, LAMBIASE P, LOWE M, et al. Brugada syndrome and anesthetic management. J Cardiothorac Vasc Anesth 2006; 20:407-13
39 COX JL, CANAVAN TE, SCHUESSLER RB, et al. The surgical treatment of atrial fibrillation: II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of the atrial flutter and atrial fibrillation. J Thorac Cardiovasc Surg 1991; 101:406-26
40 COX JL, SCHUESSLER RB, BOINEAU JP. The development of the Maze procedure for the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg 2000; 12:2-14
41 CROSSLEY G, POOLE J, ROZNER J, et al. The Heart Rhythm Society/American Society of Anesthesiologists consensus statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management. Heart Rhythm 2011; 8:1114-54
42 CRYSTAL E, CONNOLLY SJ, SLEIK LK. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: A meta-analysis. Circulation 2002; 106:75-80
43 CRYSTAL E, HEALEY J, CONNOLLY SJ. Atrial fibrillation after cardiac surgery: Update on the evidence on the available prophylactic interventions. Card Electrophysiol Rev 2003; 7:189-92
44 DARBY AE, DiMARCO JP. Management of atrial fibrillation in patients with structural heart disease. Circulation 2012; 125:945-57
45 DE VREEDE-SWAGEMAKERS JJ, GORGELS AP, DUBOIS-ARBOUW WI, et al. Out-of-hospital cardiac arrest in the 1990’s: A population-based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol 1997; 30:1500-5
46 D’SOUZA MG, NARULA DD, EHLERT FA. Anesthesia for electrophysiologic procedures. In: THYS DM et al eds. Textbook of cardiothoracic anesthesiology. New York: McGraw-Hill Co, 2001, 711-42
46a FLAMÉE P, DE ASMUNDIS C, BHUTIA JT, et al. Safe single-dose administration of propofol in opatients with established Brugada syndrome: a retrospective database analysis. Pacing Clin Electrophysiol 2013; 36:1516-21
47 FONTAINE G, FONTALIRAN F, HERBERT JL, et al. Arrhythmogenic right ventricular dysplasia. Ann Rev Med 1999; 50:17-35
48 FORREST JB, CAHALAN MK, REHDER K, et al. Multicenter study of general anesthesia. II: Results. Anesthesiology 1990; 72:262-8
49 FUSTER V, RYDEN LE, ASINGER RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary. Circulation 2001; 104:2118-50
50 FUSTER V, RYDEN LE, CANNON DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. Circulation 2006; 114:700-52
51 GAGE BF, Van WALRAVEN C, PEARCE C, et al. Selecting patients with atrial fibrillation for anticoagulation. Circulation 2004; 110:2287-92
52 GEHI A, DUONG DT, METZ LD, et al. Risk stratification of individuals with the Brugada electrocardiogram: A meta-analysis. J Cardiovasc Electrophysiol 2006; 17:577-83
53 GILLINOV AM, BLACKSTONE EH, McCARTHY PM. Atrial fibrillation: current surgical options and their assessment. Ann Thorac Surg 2002; 74:2210-7
54 GLATTER K, LIEM LB. Implantable cardioverter defibrillator: Current progress and management. Semin Cardiothorac Vasc Anesth 2000; 4:162-79
55 GO AS, HYLEK EM, PHILLIPS KA, et al. Prevalence of diagnosed atrial fibrillation in adults. JAMA 2001; 285:2370-5
56 GOMES JA, IP J, SANTONI-RUGIU F, et al. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 1999; 34:334-9
57 GREGORATOS G, ABRAMS J, EPSTEIN AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pace-makers and antiarrhythmia devices; summary article. Circulation 2002; 106:2145-61
58 GUARNIERI T, NOLAN S, GOTTLIEB SO, et al. Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trial. J Am Coll Cardiol 1999; 34:343-7
59 GUSSAK I, Autzelevitch C, Bjerregaard P, et al. The Brugada syndrome: Clinical, electrophysiologic, and genetic aspects. J Am Coll Cardiol 1999; 33:5-15
60 HABIB AS, GAN TJ. Food and Drug Administration black box warning on perioperative use of droperidol: A review of the cases. Anesth Analg 2003; 96:1377-9
61 HADDOW GR, NEVILLE M. Anesthetic implications for patients with implantable cardioverter defibrillators. Semin Cardiothorac vasc Anesth 2000; 4:187-95
62 HAÏSSAGUERRE M, VERCAL N, SACHER F, et al. Sudden cardiac arrest associated with early repolarization. N Engl J Med 2008; 358:2016-23
63 HALONEN J, HALONEN P, JARVINEN O, et al. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: A randomized controlled trial. JAMA 2007; 297:1562-7
64 HAYASHI Y, SUMIKAWA K, TASHIRO C, et al. Arrhythmogenic threshold of epinephrine during sevoflurane, enflurane and isoflurane anesthesia in dogs. Anesthesiology 1988; 69:145-9
65 HAYMAN M, FORREST P, KAM P. Anesthesia for interventional cardiology. J Cardiothorac Vasc Anesth 2012: 26:134-47
66 HESS OM. Groupe de travail «insuffisance cardiaque» de la Société Suisse de Cardiologie. Recommandations pour le diagnostic et le traitement de l’insuffisance cardiaque chronique. Bull Médecins Suisses. 2003; 84:2097-107
67 HILL LL, KATTAPURAM M, HOGUE CW. Management of atrial fibrillation after cardiac surgery – Part I: Pathophysiology and risks. J Cardiothorac Vasc Anesth 2002; 16:483-94
68 HILL LL, KATTAPURAM M, HOGUE CW. Management of atrial fibrillation after cardiac surgery – Part II: Prevention and treatment. J Cardiothorac Vasc Anesth 2002; 16:626-37
69 JIDEUS L, JOACHIMSSON PO, STRIDSBERG M, et al. Thoracic epidural anaesthesia does not influence the occurrence of postoperative sustained atrial fibrillation. Ann Thorac Surg 2001; 72:65-71
69a JONES PG, VAN DEN EYNDEN GG. Propofol infusion syndrome with arrhythmia, myocardial fat accumulation and cardiac failure. Am J Cardiol 2009; 104:1180-2
70 KASS DA, Ventricular resynchronization: pathophysiology and identification of responders. Rev Cardiovasc Med 2003; 4(suppl 2):S3-13
71 KIES SJ, PABELICK CM, HURLEY HA, et al. Anesthesia for patients with congenital long QT syndrome. Anesthesiology 2005; 102:204-10
71a KLOESEL B, ACKERMAN MJ, SPRUNG J, et al. Anesthetic management of patients with Brugada syndrome: a case series and literature review. Can J Anaesth 2011; 58:824-36
72 KOKKONEN L, MAJAHALME S, KÖÖBI T, et al. Atrial fibrillation in elderly patients after cardiac surgery: postoperative hemodynamics and low postoperative serum triiodothyronine. J Cardiothorac Vasc Anesth 2005; 19:182-7
73 KUSUMOTO FM, GOLDSCHLAGER N. Pacemakers: Types, function and indications. Semin Cardiothorac vasc Anesth 2000; 4:122-37
74 LAU W, CORCORAN SJ, MOND HG. Pacemaker tachycardia in minute-ventilation rate-adaptative pacemaker induced by electrocardiographic monitoring. Pacing Clin Electrophysiol 2006; 29:438-40
75 LINA AA, DAUCHOT PJ, ANTON AH. Epinephrine-aminophylline-induced arrhythmias after midazolam or thiopentone in halothane-anaesthetized dogs. Can J Anaesth 1991; 38:1037-43
76 MARION BJ. Hypertrophic cardiomyopathy: A systematic review. JAMA 2002; 287:1308-20
77 MARRIOTT HJL, CONOVER MB. Advanced concepts in arrhythmias, 3rd edition. StLouis: Mosby, 1998, 47-68
78 MATHEW JP. The management of arrhythmias. In: THYS DM, HILLEL Z, SCHWARTZ AJ. Textbook of cardiothoracic anesthesiology. New York: McGraw-Hill Companies, 2001, 922-45
79 MAYR A, RITSCH N, KNOTZER H, et al. Effectiveness of direct-current cardioversion for treatment of supraventricular tachyarrhythmias, in particular atrial fibrillation, in surgical intensive care patients. Crit Care Med 2003; 31:401-5
80 McCARTHY PM; GILLINOV AM, CASTLE L, et al. Cox-maze procedure for atrial fibrillation: Cleveland Clinic experience. Semin Thorac Cardiovasc Surg 2000; 12:25-9
81 McGAVIGAN AD, RANKIN AC. Arrythmias and the surgical patient. In: HOWELL S, et al, eds. Heart disease and the surgical patient. New York: Informa Healthcare, 2007,219-35
82 McMURRY SA, HOGUE CW. Atrial fibrillation and cardiac surgery. Curr Opin Anaesthesiol 2004; 17:63-70
83 MANNING WJ, SILVERMANN DI KATZ SE, et al. Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. J Am Coll Cardiol 1994; 23:1535-40
84 MILLER S, CRYSTAL E, GARFINKLE M, et al. Effects of magnesium on atrial fibrillation after cardiac surgery: A meta-analysis. Heart 2005; 91:618-23
85 MOERMAN A, HERREGODS L, TAVERNIER R, et al. Influence of anaesthesia on defibrillation threshold. Anaesthesia 1998; 53:1156-9
86 MOSS AJ. HALL WJ, CANNOM DS, et al. Improved survival with an implantable defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335:1933-40
87 NAPOLITANO C, BLOISE R, MONTEFORTE N, et al. Sudden cardiac death and genetic channelopathies. Circulation 2012; 125:2027-34
88 NEUMAR RW, OTTO CW, LINK MS, et al. Part 8: Adult Advanced Cardiovascular Life Support: 2010 American Heart Association Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2010; 122:S729-S767
89 NOLAN JP, DEAKIN CD, SOAR J, et al. European Resuscitation Council Guidelines for Resuscitation 2005. Section 4. Adult advanced life support. Resuscitation 2005; 67S1:S39-S86
90 O’FLAHERTY D, WARDILL M, ADAMS AP. Inadvertent suppression of a fixed rate ventricular pacemaker using a peripheral nerve stimulator. Anaesthesia 1993; 48:687-9
91 OLGIN JE, ZIPES DP. Specific arrhythmias: Diagnosis and treatment. In: ZIPES DP, LIBBY P, BONOW RO, BRAUNWALD E. Braunwald’s heart disease. A textbook of cardiovascular medicine. Philadelphia:Elsevier Saunders, 2005, 803-63
92 OREJARENA LA, VIDAILLET H, DESTEFANO F, et al. paroxysmal supraventricular tachycardia in the general population. J Am Coll Cardiol 1998; 31:150-7
93 PALIN CA, HOGUE CW. Atrial and ventricular arrhythmia management. In: CHENG DCH, et al, eds. Perioperative care in cardiac anesthesia and surgery. Philadelphia: Lippincott, Williams & Wilkins, 2006, 359-68
94 PALIN CA, KAILASAM R, HOGUE CW. Atrial fibrillation after cardiac surgery: pathophysiology and treatment. Semin cardiothorac Vasc Anesth 2004; 8:175é83
95 PASCALE F, JEANRENAUD X. Thérapie de resynchronisation: échocardiographie et critères de selection. Rev Med Suisse 2007; 3:1383-90
96 PASSANNANTE AN. Prevention of atrial fibrilation in cardiac surgery. Curr Opin Anesthesiol 2011; 24:58-63
97 PATEL KD, CROWLEY R, MAHAJAN A. Cardiac electrophysiology procedures in clinical practice. Intern Anesthesiol Clin 2012; 50:90-110
98 PATTI G, CHELLO M, CANDURA D, et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery. Circulation 2006; 114:1455-61
99 PHILLIPS N, PRIESTLEY M, DENNISS AR, et al. Brugada-type electrocardiographic patern induced by epidural bupivacaine. Anesth Analg 2003; 97:274-7
100 POLANCZYK CA, GOLDMAN L, MARCANTONIO ER, et al. Supraventricular arrhythmia in patients having noncardiac surgery: Clinical correlates and effect on length of stay. Ann Intern Med 1998; 129:279-85
101 POLIAC LC, BARRON ME, MARON BJ. Hypertrophic cardiomyopathy. Anesthesiology 2006; 104:183-92
102 POLL DS, MARCHINSKI FE, BUXTON AE, et al.l Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy. Circulation 1984; 70:451-6
103 RODEN DM. Drug-induced prolongations of the QT interval. N Engl J Med 2004; 350:1013-22
104 ROSEN MR, SCHWARTS PJ, et al. The Sicilian Gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation 1991; 84:1831-51
105 ROSENBLATT MA, ABEL M, FISCHER GW, et al. Successful use of 20% lipid emulsion to resuscitate a patient after a presumed bupivacaine-related cardiac arrest. Anesthesiology 2006; 105:217-8
106 ROZNER MA. The patient with a cardiac pacemaker or implanted defibrillator and management during anaesthesia. Curr Opin Anaesthesiol 2007; 20:261-8
107 RUBART M, ZIPES DP. Genesis of cardiac arrhythmias: electrophysiological considerations. In: ZIPES DP, LIBBY P, BONOW RO, BRAUNWALD E. Braunwald’s heart disease. A textbook of cardiovascular medicine. Philadelphia:Elsevier Saunders, 2005, 653-95
108 SAARNIVAARA L, LINDGREN L. Prolongation of QT interval during induction of anaesthesia. Acta Anaesthesiol Scand 1983; 27:126-30
109 SAARNIVAARA L, SIMOA M. Effects of four anticholinesterase-anticholinergic combinations and tracheal extubation on QTc interval of the ECG, heart rate and arterial pressure. Acta Anaesthesiol Scand 1998; 42:460-3
110 SAINI V, CARR DB, HAGESTAD EL, et al. Antifibrillatory action of the narcotic agonist fentanyl. Am Heart J 1988; 115:598-605
111 SALUKHE TV, DOB D, SUTTON R. Pacemakers and defibrillators: anaesthetic implications. Br J Anaesth 2004; 93:95-104
112 SANTAMBROGIO L, BRASCHI A. Conduction abnormalities and anaesthesia. Curr Opin Anaesthesiol 2007; 20:269-73
113 SANTAMBROGIO L, MENCHERINI S, FUARDO M, et al. The surgical patient with Brugada syndrome: A four-case clinical experience. Anesth Analg 2005; 100:1263-6
114 SCHAFF HV, DEARANI JA, DALY RC, et al. Cox-maze procedure for atrial fibrillation: Mayo Clinic experience. Semin Thorac Cardiovasc Surg 2000; 12:30-7
115 SCHLÄPFER J, GOY JJ. Urgences rythmiques. Praxis 1995; 84:1314-20
116 SCHWARTZ PJ, MOSS AJ, VINCENT GM, CRAMPTON RS. Diagnostic criteria for the long-QT syndrome: An update. Circulation 1993; 88:782-4
117 SCHWARTZ PJ, ZAGA A. The Sicilian Gambit revisited. Eur Heart J 1992; 13(Supppl F):23-9
118 SCOTT NB, TURFREY DJ, RAY DA, et al. A prospective randomized study of the potential benefits of thoracic epidural aesthesia and analgesia in patients undergoing coronary artery bypass grafting. Anesth Analg 2001; 93:528-35
119 SCUDERI PE. You (still) can’t disprove the existence of dragons (editorial). Anesthesiology 2005; 102:1081-2
120 SIEBELS J, KUCK KH, and the CASH Investigators. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors. Am Heart J 1994; 127:1139-44
121 SIEBRANDS CC, BINDER S, ECKHOFF U. Long QT 1 mutation KCNQ1A344V increases local anesthetic sensitivity of the slowly activating delayed rectifier potassium current. Anesthesilogy 2006; 105:511-20
121a STAIKOU C, CHONDROGIANNIS K, MANI A. Perioperative management of hereditary arrhythmogenic syndromes. Br J Anaesth 2012; 108:730-44
122 STAMOU SC, HILL PC, SAMPLE GA, et al. Prevention of atrial fibrillation after cardiac surgery – the significance of postoperative oral amiodarone. Chest 2001; 120:1936-41
123 STONE ME, SALTER B, FISCHER A. Perioperative management of patients with cardiac implantable electronic devices. Br J Anaesth 2011; 107(S1): i16-i26
124 STRICKLAND RA, STANTON MS, OLSEN KD. Prolonged QT syndrome: Perioperative management, Mayo Clin Proc 1993; 68:1016-20
125 SUMIKAWA K, ISHIZAKA N, SUZAH M. Arrhythmogenic plasma levels of epinephrine with halothane, enflurane and pentobarbital anesthesia in the dog. Anesthesiology 1983;58:322-7
126 SUNDT TM, CAMILLO CT, COX JL. The maze procedure for cure of atrial fibrillation. Cardiol Clin 1997; 15:739-48
127 TABIB A, LOIRE R, MIRAS A, et al. Unsuspected cardiac lesions associated with sudden unexpected perioperative death. Eur J Anaesthesiol 2000; 17:230-5
128 THOMPSON A, BALSER JR. Perioperative cardiac arrhythmias. Br J Anaesth 2004; 93:86-94
129 TORAMAN F, KARABULUT EH, ALHAN HC, et al. Magnesium infusion dramatically decreases the incidence of atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 2001; 72:1256-61
130 TURNER LA, BOSNJAK ZJ. Autonomic and anesthetic modulation of cardiac conduction and arrhythmias. In: LYNCH C III. Clinical cardiac electrophysiology. Philadelphia: JB Lippincott Co, 1994, pp 53-84
131 VASSOLAS G, ROTH R, VENDITTI F. Effect of extracorporeal shock wave lithotripsy on implantable cardioverter defibrillator. PACE 1993; 16:1245-8
132 VAUGHAN WILLIAMS EM. Classification of antiarrhythmic drugs. In: SANDOE E, et al, edit. Cardiac arrhythmias. Sodertalje 1970, 449-72
133 VISKIN S. Long QT syndromes and torsades de pointe. Lancet 1999; 354:1625-33
134 VRIENS EM, BAKKER PF, VRIES JW, et al. The impact of repeated short episodes of circulatory arrest on cerebral function. Reassuring EEG findings during defibrillation threshold testing at defibrillator implantation. Electroenceph Clin Neurophysiol 1996; 98:236-42
135 WEINBERG G. Lipid infusion resuscitation for local anesthetic toxicity. Anesthesiology 2006; 105:7-8
136 WERLING C, WEISSE U, SIEMON G, et al. Biventricular pacing in patients with ICD: How many patients are possible candidates ? J Thorac Cardiovasc Surg 2002; 50:67-70
137 WHITE PF, SONG D, ABRAO J, et al. Effect of low-dose droperidol on the QT interval during and after general anesthesia. Anesthesiology 2005; 102:1101-5
138 WHYTE SD, BOOKER PD, BUCKLEY DG. The effects of propofol and sevoflurane on the QT interval and transmural dispersion of repolarization in children. Anesth Analg 2005; 100:71-7
139 WIK L, HANSEN TB, FYLLING F, et al. Delaying defibrillation to give basic cardiopulmonary resuscitation to patients with out-of-hospital ventricular fibrillation: a randomized trial. JAMA 2003; 289:1389-95
140 WILKOFF BL, COOK JR, EPSTEIN AE. Dual chamber pacing versus ventricular back-up pacing in patients with an implantable defibrillator. The DAVID trial. JAMA 2002; 288:3115-23
141 WU ZK, IIVAINEN T, PEHKONEN E, et al. Fibrillation in patients subjected to coronary artery bypass grafting. J Thorac Cardiovasc Surg 2003; 126:1477-82
142 ZAIDAN JR. Implantable cardioverter-defibrillators. J Cardiothorac Vasc Anesth 1999; 13:475-83
143 ZAIDAN RJ, ATLEE JE, BELOTT P, et al. Practice advisory for the perioperative management of patients with cardiac rhythm management devices: Pacemakers and implantable cardioverter-defibrillators. Anesthesiology 2005; 103:186-98